Vertex Pharmaceuticals (Q20437): Difference between revisions

From Azupedia
Jump to navigation Jump to search
← Older editNewer edit →
‎Created claim: described at URL (P408): https://www.fiercepharma.com/pharma/after-early-win-type-1-diabetes-vertex-joins-forces-lonza-new-cell-therapy-production-plant
‎Created claim: described at URL (P408): https://www.evaluate.com/vantage/articles/events/conferences/ada-2023-vertex-raises-hopes-type-1-diabetes-cure
Property / described at URL
 
Property / described at URL: https://www.evaluate.com/vantage/articles/events/conferences/ada-2023-vertex-raises-hopes-type-1-diabetes-cure / rank
 
Normal rank
Property / described at URL: https://www.evaluate.com/vantage/articles/events/conferences/ada-2023-vertex-raises-hopes-type-1-diabetes-cure / qualifier
 

Revision as of 20:03, 16 January 2024

American pharmaceutical company
  • Vertex Pharmaceuticals Inc.
  • Vertex
Language Label Description Also known as
English
Vertex Pharmaceuticals
American pharmaceutical company
  • Vertex Pharmaceuticals Inc.
  • Vertex

Statements

instance of
business
0 references
pharmaceutical company
0 references
public company
0 references
part of
Nasdaq-100
0 references
S&P 500
0 references
logo image
VertexPharma-logo2.png
271 × 166; 6 KB
0 references
inception
1989
0 references
stock exchange
Nasdaq
ticker symbol
VRTX
0 references
described at URL
 
    Retrieved from "https://wiki.tiffa.net/w/index.php?title=Item:Q20437&oldid=109147"